However, SOX2 suppression may be permissive for a sub-set of gastric cancers with CDX2 induction to acquire mutations in epigenetic modifier genes, including ARID1A, KMT2D, KMT2C, KMT2A, and KMT2B. Here, KMT2D is linked to gastric cancer.